Helicobacter pylori Infection in Children: To Eradicate or Not to Eradicate?

Dettagli Bibliografici
Autori principali:	Marco Manfredi, Madhur Ravikumara
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Helicobacter
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Interpretation the Results of Eradicating Helicobacter pylori Infection Causing Colorectal Cancer Could Be Cautious
di: Lo‐Yip Yu, et al.
Pubblicazione: (2025)

Efficacy of Bismuth Therapy in Eradicating Helicobacter pylori in Children—Data From the RENIHp Registry
di: Gonzalo Botija, et al.
Pubblicazione: (2024)

EUROHELICAN —Accelerating Gastric Cancer Reduction Through Helicobacter pylori Eradication
di: Bojan Tepeš, et al.
Pubblicazione: (2026)

Helicobacter pylori Eradication in Older Individuals: A Systematic Review and Meta‐Analysis
di: Sun Jae Moon, et al.
Pubblicazione: (2025)

Cost‐Effectiveness of Population‐Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation
di: Akiko Kowada
Pubblicazione: (2024)

Efficacy and Safety of Keverprazan–Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial
di: Shanshan Wei, et al.
Pubblicazione: (2026)

Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐ EuReg )
di: Samuel J. Martínez‐Domínguez, et al.
Pubblicazione: (2024)

Reevaluating the Adverse Events With the Same‐Dosage Regimen in Hemodialysis Patients Undergoing Helicobacter pylori Eradication
di: Keigo Misawa, et al.
Pubblicazione: (2025)

Non‐Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis
di: Pablo Parra, et al.
Pubblicazione: (2026)

Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China
di: Xueyan Lin, et al.
Pubblicazione: (2024)

Optimal Duration of Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis
di: Miao Duan, et al.
Pubblicazione: (2024)

Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial
di: Jae Yong Park, et al.
Pubblicazione: (2026)

Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial
di: Ruolin Peng, et al.
Pubblicazione: (2025)

Eradication Rates of Empiric Helicobacter pylori Treatment Regimens by Race/Ethnicity in a Predominantly Immigrant U.S. Population
di: Min J. Kim, et al.
Pubblicazione: (2025)

Second‐ and Third‐Line Therapies for Helicobacter pylori Eradication in Slovenia: Data From 2013–2023 of the European Registry on H. pylori Management
di: Bojan Tepes, et al.
Pubblicazione: (2025)

Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp‐ BrazilReg )
di: B. S. F. Sanches, et al.
Pubblicazione: (2025)

Efficacy and Safety of Vonoprazan‐Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori Eradication: A Randomized Controlled Trial
di: Jin‐Yan Zhang, et al.
Pubblicazione: (2026)

Antibiotic Combinations in Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Network Meta‐Analysis
di: Miao Duan, et al.
Pubblicazione: (2025)

Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”
Pubblicazione: (2026)

Helicobacter pylori Eradication Is Associated With a Reduced Risk of Metachronous Gastric Neoplasia by Restoring Immune Function in the Gastric Mucosa
di: Min‐Jae Kim, et al.
Pubblicazione: (2025)

Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population‐Based Propensity‐Score‐Adjusted Analysis
di: Asaf Ness, et al.
Pubblicazione: (2025)

Impact of an Electronic Medical Record Quality Improvement Intervention on Helicobacter pylori Treatment and Eradication Rates in a U.S. Hospital System
di: Shivani Kastuar, et al.
Pubblicazione: (2025)

Seven‐Day Versus 14‐Day Tegoprazan and Tetracycline‐Containing Quadruple Therapy for First‐Line Eradication of Helicobacter pylori Infection: A Randomized, Open‐Label, Noninferiority Trial
di: Xue‐Ping Nan, et al.
Pubblicazione: (2025)

Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicrobial Resistance: A Prospective, Randomized, Single Tertiary Center Study
di: Jung Won Lee, et al.
Pubblicazione: (2024)

Helicobacter pylori Eradication Primary Care First‐Line Prescriptions: Data From 200,000 Patients in a Real‐World Cohort
di: Encarnación Fernández‐Antón, et al.
Pubblicazione: (2026)

Exosome‐Based Detection of Helicobacter pylori Infection and Clarithromycin Resistance in Children
di: Minghui Song, et al.
Pubblicazione: (2026)

Letter to the Editor: “Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential Analysis”
di: Ben‐Gang Zhou, et al.
Pubblicazione: (2025)

Real‐World Effectiveness and Safety of Saccharomyces boulardii CNCM I‐745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp‐ EuReg )
di: Olga P. Nyssen, et al.
Pubblicazione: (2026)

Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis
di: Belén Martínez Benito, et al.
Pubblicazione: (2024)

Correction to “Long‐Term Effects of Fecal Microbiota Transplantation on Gut Microbiota After Helicobacter pylori Eradication With Bismuth Quadruple Therapy: A Randomized Controlled Trial”
Pubblicazione: (2024)

Letter to the Editor: Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential Analysis—Authors' Reply
di: Vivek Mishra, et al.
Pubblicazione: (2025)

Droplet Digital PCR ‐Based Detection of Clarithromycin Resistance on Rapid Urease Test Samples Predicts Helicobacter pylori Eradication Success: A New Zealand Cohort Study
di: Stephen James Inns, et al.
Pubblicazione: (2025)

Comparative Efficacy and Safety of Potassium‐Competitive Acid Blockers and Proton Pump Inhibitors for First‐Line Helicobacter pylori Eradication Therapy: A Systematic Review and Network Meta‐Analysis
di: Mengling Ouyang, et al.
Pubblicazione: (2024)

Long‐Term Effect of Helicobacter pylori Eradication on Gastric Atrophy and Intestinal Metaplasia After Endoscopic Resection of Gastric Neoplasm: A Follow‐Up of a Randomized Controlled Trial
di: Young‐Il Kim, et al.
Pubblicazione: (2026)

Efficacy and Safety of Vonoprazan‐Based Dual Therapies With Different Antibiotics Versus Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Prospective, Four‐Arm, Randomized Controlled Trial
di: Jie Li, et al.
Pubblicazione: (2026)

Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis
di: Yuheng Zhang, et al.
Pubblicazione: (2025)

Tailored Therapy Guided by Antibiotic Genotypic Resistances and CYP2C19 Polymorphisms Detected From Fecal Specimens for the First‐Line Helicobacter pylori Eradication: A Randomized Controlled Trial
di: Baojun Suo, et al.
Pubblicazione: (2025)

Tracking the Helicobacter pylori Epidemic in Adults and Children in China
di: Zixing Wang, et al.
Pubblicazione: (2024)

Factors Associated With Decision to Treat or Not to Treat Helicobacter pylori Infection in Children: Data From the EuroPedHp Registry
di: Thu Giang Le Thi, et al.
Pubblicazione: (2024)

Reply: Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More Effective? A Three‐Arm, Multicenter Randomized Clinical Trial
di: Xinlu Ren, et al.
Pubblicazione: (2025)

Documenti analoghi

Documenti analoghi